These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 25217698

  • 1. Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1.
    Won H, Nandakumar V, Yates P, Sanchez S, Jones L, Huang XF, Chen SY.
    Blood; 2014 Oct 23; 124(17):2647-56. PubMed ID: 25217698
    [Abstract] [Full Text] [Related]

  • 2. The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis.
    Kingston D, Schmid MA, Onai N, Obata-Onai A, Baumjohann D, Manz MG.
    Blood; 2009 Jul 23; 114(4):835-43. PubMed ID: 19465690
    [Abstract] [Full Text] [Related]

  • 3. Chromatin-binding deubiquitinase MYSM1 acts in haematopoietic progenitors to control dendritic cell development and to program dendritic cell responses to microbial stimulation.
    Mousa M, Liang Y, Tung LT, Wang H, Krawczyk C, Langlais D, Nijnik A.
    Immunology; 2024 May 23; 172(1):109-126. PubMed ID: 38316548
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation.
    Anderson KL, Smith KA, Perkin H, Hermanson G, Anderson CG, Jolly DJ, Maki RA, Torbett BE.
    Blood; 1999 Oct 01; 94(7):2310-8. PubMed ID: 10498603
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Control of B cell development by the histone H2A deubiquitinase MYSM1.
    Jiang XX, Nguyen Q, Chou Y, Wang T, Nandakumar V, Yates P, Jones L, Wang L, Won H, Lee HR, Jung JU, Müschen M, Huang XF, Chen SY.
    Immunity; 2011 Dec 23; 35(6):883-96. PubMed ID: 22169041
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-2-mediated inhibition of dendritic cell development correlates with decreased CD135 expression and increased monocyte/macrophage precursors.
    Guerrero AD, Dong MB, Zhao Y, Lau-Kilby A, Tarbell KV.
    Immunology; 2014 Dec 23; 143(4):640-50. PubMed ID: 24954893
    [Abstract] [Full Text] [Related]

  • 10. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
    Harada S, Kimura T, Fujiki H, Nakagawa H, Ueda Y, Itoh T, Yamagishi H, Sonoda Y.
    Int J Oncol; 2007 Jun 23; 30(6):1461-8. PubMed ID: 17487367
    [Abstract] [Full Text] [Related]

  • 11. Myeloid development is selectively disrupted in PU.1 null mice.
    Anderson KL, Smith KA, Conners K, McKercher SR, Maki RA, Torbett BE.
    Blood; 1998 May 15; 91(10):3702-10. PubMed ID: 9573007
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.
    DeKoter RP, Walsh JC, Singh H.
    EMBO J; 1998 Aug 03; 17(15):4456-68. PubMed ID: 9687512
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dendritic cell development requires histone deacetylase activity.
    Chauvistré H, Küstermann C, Rehage N, Klisch T, Mitzka S, Felker P, Rose-John S, Zenke M, Seré KM.
    Eur J Immunol; 2014 Aug 03; 44(8):2478-88. PubMed ID: 24810486
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.